Decompensated cirrhosis and liver transplantation negatively impact in DAA treatment response: Real‐world experience from HCV‐LALREAN cohort-Reference-Cited by-同舟云学术

Decompensated cirrhosis and liver transplantation negatively impact in DAA treatment response: Real‐world experience from HCV‐LALREAN cohort

Published:2020-08-13 Issue:12 Volume:92 Page:3545-3555
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:Journal of Medical Virology

Author:

Ridruejo Ezequiel¹²^ORCID,Piñero Federico¹,Mendizabal Manuel¹^ORCID,Cheinquer Hugo³,Wolff Fernando Herz³,Anders Margarita⁴,Reggiardo Virginia⁵,Ameigeiras Beatriz⁶,Palazzo Ana⁷,Alonso Cristina¹,Schinoni María Isabel⁸,Zuain María Grazia Videla⁹,Tanno Federico⁵,Figueroa Sebastián¹⁰,Santos Luisa¹¹,Peralta Mirta¹²,Soza Alejandro¹³,Vistarini Cecilia⁶,Adrover Raúl¹⁴,Fernández Nora¹⁵,Perez Daniela⁷,Hernández Nelia¹⁶,Estepo Claudio¹⁷,Bruno Andres¹⁷,Descalzi Valeria¹⁸,Sixto Marcela¹⁹,Borzi Silvia²⁰,Cocozzella Daniel¹⁴,Zerega Alina²¹,Araujo Alexandre²²,Varón Adriana¹²,Silva Marcelo¹,

Affiliation:

1. Hepatology and Liver Transplant Unit Hospital Universitario Austral Pilar Argentina

2. Hepatology Section, Department of Medicine Centro de Educación Médica e Investigaciones Clínicas (CEMIC) Ciudad de Buenos Aires Argentina

3. Gastroenterology and Hepatology Division Universidad de Federal do Rio Grande do Sul Porto Alegre Brazil

4. Gastroenterology and Hepatology Division Hospital Alemán Ciudad de Buenos Aires Argentina

5. Gastroenterology and Hepatology Division Hospital Provincial del Centenario Rosario Argentina

6. Gastroenterology and Hepatology Division Hospital Ramos Mejía Ciudad de Buenos Aires Argentina

7. Gastroenterology and Hepatology Division Hospital Padilla Tucumán Argentina

8. Gastroenterology and Hepatology Division Universidade Federal do Bahia Salvador do Bahia Brazil

9. Gastroenterology and Hepatology Division Hostpial Zubizarreta Ciudad de Buenos Aires Argentina

10. Gastroenterology and Hepatology Division Hospital Arturo Oñativia Salta Argentina

11. Gastroenterology and Hepatology Division Fundación Cardioinfantil Bogotá Colombia

12. Liver Unit Hospital Francisco J. Muñiz Ciudad de Buenos Aires Argentina

13. Gastroenterology and Hepatology Division Hospital Pontificia Universidad Católica de Chile Santiago Chile

14. Gastroenterology and Hepatology Division Hospital San Roque La Plata Argentina

15. Gastroenterology and Hepatology Division Hospital Británico Ciudad de Buenos Aires Argentina

16. Gastroenterology and Hepatology Division Hospital de Clínicas Montevideo Uruguay

17. Gastroenterology and Hepatology Division Hospital Cosme Argerich Ciudad de Buenos Aires Argentina

18. Hepatology and Liver Transplant Unit Fundación Favaloro Ciudad de Buenos Aires Argentina

19. Gastroenterology and Hepatology Division Hospital José María Cullen Santa Fe Argentina

20. Gastroenterology and Hepatology Division Hospital Rossi La Plata Argentina

21. Hepatology and Liver Transplant Unit Sanatorio Allende Córdoba Argentina

22. Gastroenterology and Hepatology Division Hospital de Clínicas de Porto Alegre de Porto Alegre Brazil

Funder

Instituto Nacional del Cáncer

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.26383

Reference36 articles.

1. WHO Global hepatitis report;2017.http://apps.who.int/iris/bitstream/10665/255016/1/9789241565455-eng.pdf?ua=1. Accessed March 30 2020.

2. PAHO and WHO OPS/OMS alienta a los países de las Américas a actuar para reducir muertes por hepatitis y mejorar prevención y el tratamiento; 2017.http://www.paho.org/hq/index.php?option=com_content&view=article&id=12334%3Aopsoms-alienta-paises-americas-reducir-muertes-por-hepatitis&Itemid=1926&lang=es. Accessed March 30 2020.

3. EASL Recommendations on Treatment of Hepatitis C 2018

4. American Association for the Study of Liver Disease (AASLD).http://www.hcvguidelines.org/full-report-view. Accessed March 30 2020.

5. B.A.R.C.O.S. (Brazilian Argentine Hepatitis C Collaborative Observational Study): Effectiveness and clinical outcomes of HCV treatment with daclatasvir and sofosbuvir with or without ribavirin

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Direct-Acting Antiviral Therapy for Patients with Chronic Hepatitis C Infection and Decompensated Cirrhosis;Digestive Diseases and Sciences;2024-04-05

2. Rescue Therapy after Failure of HCV Antiviral Treatment with Interferon-Free Regimens;Viruses;2023-03-04

3. Role of Serum Vitamin D, Interleukin 13, and microRNA-135a in Hepatocellular Carcinoma and Treatment Failure in Egyptian HCV-Infected Patients Receiving Direct Antiviral Agents;Viruses;2021-10-06

4. Early liver function improvement following successful treatment of chronic hepatitis C in patients with decompensated cirrhosis: a real-life study;Clinics;2021

5. Direct‐acting antiviral treatment failure in genotype 2 hepatitis C chronic infection;Journal of Viral Hepatitis;2020-11-18